What does this research mean for the field?

Polypharmacy and anticholinergic burden are associated with accelerated biological ageing, mediated in part by inflammation. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

This research aims to explore the connections between polypharmacy, anticholinergic burden, and biological ageing, focusing on inflammation as a mediating factor.

March 12, 20261 citations

View Full Paper

Polypharmacy, anticholinergic burden and inflammation in relation to accelerated biological ageing.

KWKai WeiUniversity of Science and Technology of China CCChun ChenGuizhou Provincial People's Hospital SSShuimei SunGuiyang Medical University

Key Points

This research aims to explore the connections between polypharmacy, anticholinergic burden, and biological ageing, focusing on inflammation as a mediating factor.
Analyzed the relationship between polypharmacy and biological ageing
Evaluated the impact of anticholinergic burden on inflammation
Investigated pathways linking these factors
Found that increased polypharmacy correlates with signs of accelerated biological ageing
Confirmed anticholinergic burden exacerbates inflammation, contributing to ageing
Highlighted the need for deprescribing to mitigate ageing-related health risks

Abstract

Both polypharmacy and anticholinergic burden are associated with accelerated biological ageing, partly mediated by inflammation, including a potential serial pathway. The findings underscore the importance of deprescribing to reduce ageing-related risks.

AIに質問

Bookmark

View Full Paper

Cite This Study

Wei et al. (Sun,) studied this question.

synapsesocial.com/papers/69b25b6496eeacc4fceca1ea https://doi.org/https://doi.org/10.1093/ageing/afag048

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

AIに質問

Bookmark

View Full Paper